Delivery Order SPE2DB22D2006-SPE2DB25FW0BT
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$21K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,874,461 units of the medication Dupixent 300 mg/2 ml syringe 2 ml. The contract is a firm fixed-price, non-set-aside contract with a ceiling value of $1,709.46 and a performance period through April 11, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,837.84, is for the delivery of 4,567,874,487 units of the medication Dupixent 300 mg/2 ml syringe. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 11, 2025. This order is not associated with a set-aside program and is open to full and open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,249,562 units of the prescription medication Dupixent 300 mg/2 ml syringe, 2 ml. The contract has a firm fixed price of $29,464.17 and a period of performance through May 15, 2025. This award is not associated with a set-aside program and appears to be an open competition....
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,771.14 contract is for the supply of 4,567,915,220 units of Dupixent 300 mg/2 ml syringes. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml syringes, a medication used to treat certain medical conditions. The contract has a firm fixed price of $7,097.38 and a completion date of May 16, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds...
This is a delivery order award valued at $22,831.30 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,192,442 units of the drug Dupixent 200 mg/1.14 ml syringe, with a performance period through May 9, 2025. The contract is a firm fixed-price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,005.76, is for the delivery of 4,568,093,130 units of the prescription medication Dupixent 300 mg/2 ml pen. The contract is a firm fixed-price, non-set-aside award with a performance period through May 1, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,897.71 firm fixed-price contract is for the delivery of 4,564,661,051 units of Dupixent 300 mg/2 mL syringes, with a final completion date of May 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,999.06, is for the supply of 4,568,117,353 units of the medication Dupixent 300 mg/2 ml syringe. The award has an ultimate completion date of May 5, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml syringes, a medication used for various medical conditions. The contract has a ceiling value of $10,074.28 and is a firm fixed-price delivery order with a completion date of May 19, 2025. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery...